MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neurogenic bladder and affective disorders in parkinsonism

E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva (Moscow, Russian Federation)

Meeting: 2025 International Congress

Keywords: Multiple system atrophy(MSA): Clinical features, Parkinson’s, Parkinsonism

Category: MSA, PSP, CBS: Clinical Trials

Objective: To determine the relationship between psychoemotional and dysuria dysfunctions in patients with PD and MSA.

Background: In the group of patients with extrapyramidal pathology the possible correlation between psychoemotional and urinary disorders remains unclear.

Method: Patients with Parkinson’s disease (n=53) and multiple system atrophy (n=18), diagnosed according to modern criteria, were included. Parkinson’s disease stages were assessed using the Hoehn and Yahr (HY) scale. To estimate symptoms we used the bladder function assessment scale developed by us and the Hospital Anxiety and Depression Scale (HADS). Urodynamic testing (cystometry, pressure/flow) was performed in five patients with early stages of Parkinson’s disease.

Results: The patients were divided into two groups:

I – Parkinson’s disease – 53 patients, 2.9±1.0 HY (average);

II – multiple system atrophy – 18 patients.

In the given groups among patients with Parkinson’s disease, there was a statistically significant increase in the sum of storage scores and the total sum of scores (p<0.001), no statistically significant increase was noted as the severity of the disease stage increased (p=0.063). In multiple system atrophy patients the initial and late periods of the disease did not significantly differ in any of the above parameters.

The correlation of affective symptoms was as follows: in the Parkinson’s disease group there is a statistically significant, direct, moderate or noticeable correlation between symptoms of anxiety, depression and urological indicators with the sum of storage scores (p<0.001); voiding scores (p<0.001) and with the total sum of scores (p<0.001). Within the I group HADS subscale indicators (anxiety and depression) were compared between patients with and without lower urinary tract symptoms. Patients without urinary disorders demonstrated statistically significantly lower scores on both anxiety and depression subscales (p≤0.001). Urodynamic tests did not obtain urodynamic confirmation of the urinary disorders complained by patients.

Conclusion: At the early stages of Parkinson’s disease lower urinary tract symptoms are most often of a psychoemotional nature and are not confirmed by the results of an objective urodynamic testing.

To cite this abstract in AMA style:

E. Korshunova, M. Khommyatov, M. Samushiya, N. Suponeva. Neurogenic bladder and affective disorders in parkinsonism [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/neurogenic-bladder-and-affective-disorders-in-parkinsonism/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neurogenic-bladder-and-affective-disorders-in-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley